DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Gillen D.
Direct healthcare professional communication regarding serious adverse reactions following off-label use of Vistide.[letter].
Vistide DHPC letter.
http://wwwcbg-mebnl/NR/rdonlyres/FFB51936-EC22-4180-A213-9E907F06A774/011pdf 2011
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.